top of page

Institutional Review Board

The QAZIIM Institutional Review Board (IRB) is an independent ethical oversight body responsible for the ethical evaluation and continuous monitoring of biomedical and translational research conducted at the institute.

The IRB reviews studies involving:

  • human participants,

  • biological specimens,

  • genetic and multi-omics data,

  • clinical interventions, registries, and AI-based medical research.

The Board evaluates research protocols for:

  • scientific and ethical justification,

  • risk–benefit balance,

  • participant protection measures,

  • informed consent procedures,

  • data privacy and confidentiality,

  • compliance with applicable laws and international ethical frameworks.

The IRB operates in accordance with:

  • principles of the Declaration of Helsinki,

  • ICH-GCP (Good Clinical Practice) guidelines,

  • CIOMS international ethical guidelines,

  • and national regulatory requirements of the Republic of Kazakhstan.

IRB application documents

SOP-2. IRB Committee Meetings

SOP-3. Initial Review of Clinical Research Documentation

SOP-4. Ethical Review of Clinical Research Studies

SOP-5. Ethical Review of Experimental (Preclinical) Research Studies

SOP-6. Review of Documentation for New Treatment and Diagnostic Technologies

SOP-7. Monitoring of Study Progress

SOP-8. Requirements for Informed Consent of Research Participants

SOP-9. Requirements for Investigators

SOP-10. Confidentiality and Data Protection

SOP-11. Safety Reporting

SOP-12. Serious Adverse Events (SAE) Reporting

SOP-13. Early Termination or Suspension of a Study/Trial

SOP-14. Review of the Final Study Report

© 2025 by QazIIM

020000, Qorgalzhyn tas zholy 30, Astana, Kazkhstan

+7 702 986 24 08

  • White Facebook Icon
  • Instagram
  • Whatsapp
  • Telegram
bottom of page